Last updated: July 8, 2015
Sponsor: University of Illinois at Chicago
Overall Status: Completed
Phase
3
Condition
Holoprosencephaly
Birth Defects
Treatment
N/AClinical Study ID
NCT00741858
UIC 2002-0232
Ages 18-70 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Symptomatic Chiari malformation
Exclusion
Exclusion Criteria:
Presence of ventriculoperitoneal shunt
Pregnancy
Study Design
Total Participants: 34
Study Start date:
April 01, 2003
Estimated Completion Date:
April 30, 2010
Study Description
Connect with a study center
University of Illinois Medical Center in Chicago
Chicago, Illinois 60612
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.